Pentraxin 3 as a Marker for Cardiovascular Disease Risk in Overweight and Obese Children

Pinar Dervisoglu1, Bahri Elmas2

  • 1Department of Pediatric Cardiology.

Insights

Elevated pentraxin 3 levels indicate increased cardiovascular risk in overweight and obese children. This inflammatory marker may serve as an early predictor of cardiovascular disease in pediatric populations.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Research
  • Inflammation Biomarkers

Background:

  • Pentraxin 3 (PTX3) is an inflammatory mediator implicated in atherosclerosis and cardiovascular diseases.
  • Subclinical inflammation is a concern in overweight and obese children, potentially increasing cardiovascular risk.

Purpose of the Study:

  • To investigate the predictive value of pentraxin 3 (PTX3) as an inflammatory biomarker in overweight and obese children.
  • To assess the association of PTX3 levels with cardiovascular parameters in these pediatric groups.

Main Methods:

  • A comparative study involving three groups: overweight (n=35), obese (n=35), and healthy controls (n=70).
  • Measurement of cardiovascular parameters and serum pentraxin 3 (PTX3) levels in all participants.
  • Correlation and regression analyses were performed to identify associations between PTX3, anthropometric, and cardiovascular measures.

Main Results:

  • Significantly higher PTX3 levels were observed in overweight and obese children compared to healthy controls.
  • PTX3 levels correlated with carotid intima media thickness and epicardial adipose tissue thickness in the overweight group.
  • Receiver operating characteristic (ROC) analysis identified optimal PTX3 cut-off values for predicting obesity and overweight status, with moderate sensitivity and specificity.

Conclusions:

  • Pentraxin 3 (PTX3) may serve as an early indicator of cardiovascular risk in overweight and obese children.
  • Further longitudinal studies are warranted to confirm the predictive capability of PTX3 for future cardiovascular events in pediatric populations.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
324
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
352
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
516